[{"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1526-2014", "product_description": "Super MIC B Complex for L-Carnitine for Injection USP with Methylcobalamin 1000 mcg/ml, Sterile, for IM or Deep SQ Use, Multiple Dose Vial. Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077987"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-558", "16714-559", "16714-560", "16714-570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["fa078b35-ee9d-4b9f-bb8d-e77949c09f88"], "spl_set_id": ["ce15ad07-3286-478f-9f30-1db6a45ed402"], "package_ndc": ["16714-558-01", "16714-558-02", "16714-559-01", "16714-559-02", "16714-560-01", "16714-560-02", "16714-570-01", "16714-570-02"], "is_original_packager": [true], "upc": ["0316714570013", "0316714559018", "0316714560014"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0349-2025", "product_description": "Pravastatin Sodium Tablets, USP, 20mg, a).90-count bottle, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-559-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17230810, exp. date Mar-26"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) may be potentially mislabeled as    VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: W002767, EXP: 6/6/2014;  LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD60240_20, EXP: 5/22/2014;  PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: AD73521_25, EXP: 5/30/2014.", "address_2": "", "product_quantity": "900 Tablets", "code_info": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) has the following codes    Pedigree: W002699, EXP: 6/5/2014;  Pedigree: AD60240_27, EXP: 5/22/2014;  Pedigree: AD73521_28, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-471-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75212", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Oklahoma", "recall_number": "D-0004-2017", "product_description": "Tri-Mix 18/1/10 (Papaverine 18mg, Phentolamine 1 mg, Prostaglandin 10 mcg/mL) packaged in 2.5 mL sterile vials, IM, Rx, The Apothecary Shoppe, Jenks, OK", "product_quantity": "247.5 mL total volume", "reason_for_recall": "Lack of Assurance of Sterility; medication was sterilized with a recalled filter", "recall_initiation_date": "20160912", "center_classification_date": "20161004", "termination_date": "20180125", "report_date": "20161012", "code_info": "07252016@22 BUD 09/22/2016; 08102016@28 BUD 10/08/2016"}, {"status": "Terminated", "city": "Cambridge", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205874"], "brand_name": ["AURYXIA"], "generic_name": ["FERRIC CITRATE"], "manufacturer_name": ["Akebia Therapeutics, Inc."], "product_ndc": ["59922-631"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TETRAFERRIC TRICITRATE DECAHYDRATE"], "rxcui": ["1594680", "1596023"], "spl_id": ["c7578bda-1b89-4881-95cd-f1201508871f"], "spl_set_id": ["aadd18e0-3752-11e4-8510-0800200c9a66"], "package_ndc": ["59922-631-01"], "is_original_packager": [true], "unii": ["Q91187K011"]}, "product_type": "Drugs", "event_id": "86955", "recalling_firm": "Akebia Therapeutics dba Keryx Biopharmaceutials, Inc", "address_1": "245 1st St", "address_2": "N/A", "postal_code": "02142-1200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.", "recall_number": "D-0170-2021", "product_description": "Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA  02210, NDC 59922-631-01", "product_quantity": "2,170 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201209", "center_classification_date": "20201218", "termination_date": "20210901", "report_date": "20201230", "code_info": "Lot Number: 9062, exp. date Feb 2021"}, {"status": "Terminated", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90398", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1487-2022", "product_description": "CALCIUM CARBONATE ORAL SUSPENSION, 1250 mg/5 mL, 5 mL cup, packaged in 10 cups per tray, 4 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152, NDC 0904-7098-94", "product_quantity": "49,280 cups", "reason_for_recall": "CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.", "recall_initiation_date": "20220607", "center_classification_date": "20220906", "termination_date": "20250625", "report_date": "20220914", "code_info": "Lot # 21021A, 21023A, 21024A, EXP Feb. 2023; 21064A, EXP Jun. 2023; 21073A, 21075A, EXP Jul. 2023; 21100A, EXP Sep. 2023; 21118A, 21120A, EXP Nov. 2023; 21128A, 21129A, 21131A, 21135A, EXP Dec. 2023; 22019A, EXP Mar. 2024."}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88662", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AZ, CO, FL, IL, NJ", "recall_number": "D-0803-2021", "product_description": "MIC+Methyl B12 injection Methionine Inositol Choline+Methylcobalamin 25 mg/50 mg/50 mg/1 mg/mL, 10 mL vial sterile, Rx only, Promise Pharmacy 31818 US Hwy 19N Palm Harbor FL 34684 1-888-3PROMIS", "product_quantity": "57 vials", "reason_for_recall": "Lack of processing controls", "recall_initiation_date": "20210630", "center_classification_date": "20210916", "termination_date": "20230606", "report_date": "20210922", "code_info": "Lot# 06152021@2, Exp 09/13/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74135", "recalling_firm": "Profarma Distributors LLC", "address_1": "4751 Poth Rd", "address_2": "N/A", "postal_code": "43213-1331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1043-2016", "product_description": "1% Clotrimazol cream, 30 mg tube,  UPC 501318644335", "product_quantity": "79 boxes (79 tubes)", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20160511", "center_classification_date": "20160617", "termination_date": "20170124", "report_date": "20160629", "code_info": "Lot # GRU1390; Exp. 08/17"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0346-2015", "product_description": "Imipenem/ cilastatin various strength in normal saline bags", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "22 units", "code_info": "Rx # 28289, Exp 02/5/14; Rx # 29189, Exp 05/23/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Vancomycin 750 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28289, Discard After 02/5/14; Rx # 29189, Discard After 05/23/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1454-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0279-2017", "product_description": "Pyridoxine HCL 100 mg/ml, (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 08162016A (02/12/2017)."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "19 units", "code_info": "Rx #'s:  0398081      0397941    0407446    0397941    0398081          0409508    0356693    0374227      0356693      0400766        0374227", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "IOHEXOL 200MG IODINE/ML INJECTABLE\t120 ML  \t  \t300 ML  \t50 ML  \t600 ML  \t72 ML;  \t  \t  \t  IOHEXOL,  4ML VIAL 240MG IODINE/ML INJECTABLE\t200 ML;  IOHEXOL, 3ML VIAL 300MG IODINE/ML INJECTABLE\t180 ML  \t600 ML  \t  \t90 ML  \t  \t  \t  \t  \t900 ML  (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1548-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0503-2023", "product_description": "Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701", "product_quantity": "", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot # a): J0656821-103122, Exp. Date 11/30/2023; J0638547-080922, Exp. Date 08/31/2023; J0633575-071822, Exp. Date 07/31/2023  Lot #: b): B1965081-111622, Exp. Date 03/31/2025; B1857922-091922, B1765298-071322, B1786319-072922, B1706842-053122, Exp. Date 04/30/2023; B2003311-120822, Exp. Date 04/30/2025; B1955679-111122, Exp. Date 02/28/2025; B1878942-092922, Exp. Date 11/30/2024; B1823203-082622. Exp. Date 10/31/2024; B1706843-053122, Exp. Date 05/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Claremont", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84279", "recalling_firm": "Natures Rx", "address_1": "310 N Indian Hill Blvd", "address_2": "Ste 600", "postal_code": "91711-4611", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0633-2020", "product_description": "Silver Bullet, Get Bigger and Harder, Works in Minutes, Lasts for Days, 10 male enhancement capsules in blister foil package, 725mg per capsule, Distributed by Silver Bullet Ltd, Golden Springs, CO, USA, UPC: 610877392698.", "product_quantity": "2,800 capsules", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; Product contains undeclared active ingredient - Sildenafil.", "recall_initiation_date": "20191113", "center_classification_date": "20191231", "termination_date": "20230208", "report_date": "20200108", "code_info": "Lot  # 01251ZX1, exp. date 11/2022  UPC: 610877392698"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076658"], "brand_name": ["FLUCONAZOLE"], "generic_name": ["FLUCONAZOLE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6500", "0904-6501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUCONAZOLE"], "rxcui": ["197698", "197700"], "spl_id": ["a734a240-4f7d-447f-8eb0-19c16465c57a"], "spl_set_id": ["13184b13-e252-4b4d-a3e2-cfc4ad3d55b7"], "package_ndc": ["0904-6500-06", "0904-6500-61", "0904-6501-06", "0904-6501-61"], "original_packager_product_ndc": ["55111-144", "55111-146"], "nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["8VZV102JFY"]}, "product_type": "Drugs", "event_id": "77106", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0688-2017", "product_description": "Fluconazole Tablets, USP, 100 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Distributed by MAJOR PHARMACEUTICALS, 31778 Enterprise Dr., Livonia, MI 48150 USA, NDC 0904-6500-61", "product_quantity": "2,341 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170105", "center_classification_date": "20170428", "termination_date": "20170804", "report_date": "20170510", "code_info": "Lot#: T-00520, EXP 02-17, T-00632, T-00699, EXP. 04-17", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0543-2016", "product_description": "Folic Acid 1 mg/0.2 mL syringe, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "23 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80097", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0838-2018", "product_description": "My Way (levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD  21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454 775, INDIA, UPC 3 68180 85212 4.", "product_quantity": "43,640 cartons", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.", "recall_initiation_date": "20180517", "center_classification_date": "20180531", "termination_date": "20190501", "report_date": "20180530", "code_info": "Lot #: L700329, Exp 08/19; L700670, Exp 11/19"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Lidocaine all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0796-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82335", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "California, Georgia, Indiana", "recall_number": "D-1051-2019", "product_description": "Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc. 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807.", "product_quantity": "530", "reason_for_recall": "CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.", "recall_initiation_date": "20190306", "center_classification_date": "20190321", "termination_date": "20230330", "report_date": "20190327", "code_info": "Count, lots, expiry: a) 30-count bottle C2218C, exp 9/2020, D1318E, exp 10/2020; b) 90-count bottle C2719J, exp 9/2020, E1818B, exp 10/2020."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0378-2021", "product_description": "Haloperidol Decanoate Injection, USP 100 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, Teva Pharmaceuticals, USA, Inc., North Wales, PA  NDC 0703-7131-03", "product_quantity": "7020 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "Lot # 31325394C, exp. date 09/2021 Lot # 31327161B, exp. date 04/2022"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; HYDRALAZINE HCL Tablet, 25 mg may be potentially mislabeled as    DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD49582_16, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "HYDRALAZINE HCL, Tablet, 25 mg has the following code    Pedigree: AD49610_4, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "HYDRALAZINE HCL Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 50111032701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-590-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Unknown", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "96833", "recalling_firm": "EnShiShiXiangNiShangMaoYouXianGongSi", "address_1": "Unknown", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide Via Amazon Platform", "recall_number": "D-0453-2025", "product_description": "ENDURANCE BOOST WITH HORNY GOAT WEED, 500mg, 20 capsules per carton,  VEPEMVA Nutrition Supplement....rgy and Endurance, UPC X004BB9Z8N", "product_quantity": "600, 20-count cartons", "reason_for_recall": "Marketed without approved NDA/ANDA: The product has been found to be tainted with  Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).", "recall_initiation_date": "20250506", "center_classification_date": "20250529", "report_date": "20250604", "code_info": "Lot: 250214PRO, Expiration Date: 02/14/2027."}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89036", "recalling_firm": "Medline Industries Inc", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Canada, Hong Kong, and Peru", "recall_number": "D-0287-2022", "product_description": "Hand Sanitizer Foam (ethyl alcohol), 62% v/v, packaged in a) 1.5 Oz. cans, NDC 53329-970-12; b) 8 Oz. (227 g) cans, NDC 53329-970-08; and c) 16 Oz. (453 g) cans, NDC 53329-970-06;  Manufactured for: Medline Industries, Inc., Northfield, IL 60093.", "product_quantity": "470,555 bottles", "reason_for_recall": "Defective Container: Customer complaints for leaking bottles and dispensing issues.", "recall_initiation_date": "20211108", "center_classification_date": "20211217", "termination_date": "20240828", "report_date": "20211229", "code_info": "Lot #: a) 32890, exp 04/2022; 33141, 33215, exp 10/2022; 33350, exp 12/2022; 33461, exp 03/2023; b) 32858, exp 02/2022; 32889, exp 03/2022; 32968, 32977, 32975, 32984, exp 06/2022; 33294, 33295, 33322, 33323, exp 12/2022; 33384, exp 01/2023; Lot 33620, exp 07/2023; c) 32728, exp 10/2021; 32859, 32889, exp 03/2022; 32985, 32988, 33004, exp 06/2022; 33339, exp 12/2022; 33501, exp 03/2023; 33502, exp 04/2023; 33621, 33622, exp 07/2023"}, {"status": "Ongoing", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213368"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-047", "16714-048", "16714-049", "16714-050", "16714-051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["13fe8f97-37e8-4d10-87fe-e1d17f4f23d8"], "spl_set_id": ["2bd42d3a-bf89-4d74-a252-9b914106a570"], "package_ndc": ["16714-047-01", "16714-048-01", "16714-049-01", "16714-050-01", "16714-051-01"], "is_original_packager": [true], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "97534", "recalling_firm": "Zydus Pharmaceuticals (USA) Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0635-2025", "product_description": "Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Manufactured for: Northstar Rx LLC Memphis, TN 38141.  NDC: 16714-049-01", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit", "recall_initiation_date": "20250903", "center_classification_date": "20250910", "report_date": "20250917", "code_info": "Lot #: Z306326, Exp Date 30-11-25; Z401155, Exp Date 28-02-26"}, {"status": "Terminated", "city": "Deltona", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67471", "recalling_firm": "MyNicNaxs, Inc.", "address_1": "1012 Alpine Dr", "address_2": "N/A", "postal_code": "32725-7204", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1375-2014", "product_description": "Pill for weight reduction, (Japanese Chinese Formula from Japan Hokkaido Cangye Pharmacy Co, Ltd) 400 mg, supplied in 40 count boxes, distributed by MyNicKnaxs, LLC, Deltona, FL", "product_quantity": "unknown", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein", "recall_initiation_date": "20140124", "center_classification_date": "20140612", "termination_date": "20191002", "report_date": "20140618", "code_info": "ALL LOTS"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "435 vials and syringes", "code_info": "Lot #: 13012320-GV1, Exp 4/23/2013; 13021840GV1, Exp 5/18/2013; 13031150GV1, Exp 6/11/2013; 13021840GV1, Exp 5/18/2013; 13012320-GV1, Exp 4/23/2013; 13011532, Exp 4/15/2013.", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "BET-ACE-LIDO-6-2 Injection, all strengths and all presentations including 7 mL syringe and Betameth Combo 6 mg/mL Lidocaine 2% Syringe, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-347-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA215802"], "brand_name": ["LISDEXAMFETAMINE DIMESYLATE"], "generic_name": ["LISDEXAMFETAMINE DIMESYLATE"], "manufacturer_name": ["Lannett Company, Inc."], "product_ndc": ["0527-4661", "0527-4662", "0527-4663", "0527-4664", "0527-4665", "0527-4666", "0527-4667"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISDEXAMFETAMINE DIMESYLATE"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_id": ["7ac942a6-689a-420b-87bf-dc59003400dc"], "spl_set_id": ["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"], "package_ndc": ["0527-4661-37", "0527-4662-37", "0527-4663-37", "0527-4664-37", "0527-4665-37", "0527-4666-37", "0527-4667-37"], "is_original_packager": [true], "upc": ["0305274664379", "0305274666373", "0305274661378", "0305274665376", "0305274667370", "0305274663372"], "unii": ["SJT761GEGS"]}, "product_type": "Drugs", "event_id": "95630", "recalling_firm": "Lannett Company Inc.", "address_1": "1101 C Ave W", "address_2": "", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0112-2025", "product_description": "Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC:  0527-4661-37", "product_quantity": "1608 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.", "recall_initiation_date": "20241025", "center_classification_date": "20241205", "termination_date": "20250627", "report_date": "20241211", "code_info": "Lot: 23274856A, Exp 04/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0707-2023", "product_description": "oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6039-1.", "product_quantity": "21871 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-889853, 37-889854, 37-889856, Exp 04/30/2023; 37-890087, 37-890088, 37-890095, 37-890098, 37-890100, 37-890107, 37-890109, Exp 05/03/2023; 37-890876, 37-890878, 37-890885, 37-890891, Exp 05/05/2023; 37-891572, Exp 05/07/2023; 37-892504, 37-892510, 37-892512, 37-892520, 37-892560, 37-892575, 37-892585, 37-892587, Exp 05/12/2023; 37-892988, 37-892989, Exp 05/13/2023; 37-894323, 37-894356, 37-894366, 37-894385, 37-894386, 37-894402, 37-894409, 37-894410, Exp 05/19/2023; 37-894778, Exp 05/20/2023; 37-894998, 37-894999, 37-895000, 37-895001, 37-895002, Exp 05/21/2023; 37-896186, 37-896189, 37-896192, 37-896194, 37-896200, 37-896202, 37-896227, 37-896231, 37-896240, 37-896241, Exp 05/26/2023; 37-896844, 37-896851, 37-896853, 37-896856, Exp 05/28/2023; 37-897827, 37-897836, 37-897837, 37-897853, 37-897854, 37-897928, Exp 06/02/2023; 37-900117, 37-900122, 37-900123, Exp 06/10/2023"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1414-2016", "product_description": "3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Hospira LifeCare Bag, Service Code 2H8180 (NDC 61553-180-52), 250 mL in 250 mL Hospira LifeCare Bag  Service Code 2H8262 (NDC 61553-262-50),  250 mL in 250 mL Baxter Intravia Bag, Service Code 2K8180 (NDC 61553-180-02), Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141", "product_quantity": "345 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2H8180 , Lot Number 160450152M , Exp. Date 5/11/2016 ;  Service Code 2H8180 , Lot Number 160830040M , Exp. Date 6/17/2016 ;  Service Code 2H8262 , Lot Number 160380102M , Exp. Date 5/8/2016 ;  Service Code 2H8262 , Lot Number 160750131M , Exp. Date 6/14/2016 ;  Service Code 2H8262 , Lot Number 161080121M , Exp. Date 7/17/2016 ;  Service Code 2K8180 , Lot Number 160460038C , Exp. Date 5/10/2016 ;  Service Code 2K8180 , Lot Number 160480026C , Exp. Date 5/12/2016 ;  Service Code 2K8180 , Lot Number 160550022C , Exp. Date 5/19/2016 ;  Service Code 2K8180 , Lot Number 160620021C , Exp. Date 5/26/2016 ;  Service Code 2K8180 , Lot Number 160680038C , Exp. Date 6/1/2016 ;  Service Code 2K8180 , Lot Number 160760022C , Exp. Date 6/9/2016 ;  Service Code 2K8180 , Lot Number 160770042C , Exp. Date 6/10/2016 ;  Service Code 2K8180 , Lot Number 160830034C , Exp. Date 6/16/2016 ;  Service Code 2K8180 , Lot Number 160900094C , Exp. Date 6/23/2016 ;  Service Code 2K8180 , Lot Number 160940033C , Exp. Date 6/27/2016 ;  Service Code 2K8180 , Lot Number 160970035C , Exp. Date 6/30/2016 ;  Service Code 2K8905 , Lot Number 160810187M , Exp. Date 6/11/2016 ;  Service Code 2K8905 , Lot Number 160890186M , Exp. Date 6/18/2016 ;  Service Code 2K8975 , Lot Number 160550132M , Exp. Date 5/15/2016 ;  Service Code 2K8975 , Lot Number 160610229M , Exp. Date 5/22/2016 ;  Service Code 2K8975 , Lot Number 160770165M , Exp. Date 6/7/2016 ;", "more_code_info": ""}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80847", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1135-2018", "product_description": "Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90", "product_quantity": "14016 bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180817", "center_classification_date": "20180828", "report_date": "20180905", "code_info": "Batch: BV47C005, BV47C006, BV47D001, BV47C003, BV47C004"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204613"], "brand_name": ["CIPROFLOXACIN HCL OPHTHALMIC"], "generic_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "manufacturer_name": ["Altaire Pharmaceuticals Inc."], "product_ndc": ["59390-217"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["309307"], "spl_id": ["f31149b7-60fc-4cef-8270-5eb8ff2b42bb"], "spl_set_id": ["41363a06-d6f5-4bc6-b0e9-34e5616ae387"], "package_ndc": ["59390-217-02", "59390-217-05", "59390-217-10"], "is_original_packager": [true], "upc": ["4776638217054"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0478-2020", "product_description": "Altaire Ciprofloxacin HCl Ophthalmic Solution, 0.3%, 5 mL, NDC 59390-217-05", "product_quantity": "6024 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 18164, Exp 7/20"}, {"status": "Terminated", "city": "Sanford", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA019452"], "brand_name": ["DERMOTIC"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Royal Pharmaceuticals"], "product_ndc": ["68791-103"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191299", "1191301"], "spl_id": ["195c48d9-bb7a-4c89-b6b8-35fff5aefff8"], "spl_set_id": ["eb00f222-8105-4e05-90e8-bbd129784364"], "package_ndc": ["68791-103-20"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "67420", "recalling_firm": "Hill Dermaceuticals, Inc.", "address_1": "2650 S Mellonville Ave", "address_2": "N/A", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1178-2014", "product_description": "ROYAL PHARMACEUTICALS DermOtic Oil fluocinolone acetonide 0.01% (Ear Drops), 20 ml,  Rx only  Manufactured by: Hill Dermaceuticalsfor: Royal Pharmaceuticals NDC 68791-103-20", "product_quantity": "13,379 bottles", "reason_for_recall": "Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.", "recall_initiation_date": "20140131", "center_classification_date": "20140324", "termination_date": "20150203", "report_date": "20140402", "code_info": "13F015B exp. 12/14, 13G023B exp. 01/15"}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "ESTRIOL Creams, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0494-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0861-2020", "product_description": "CVS Health Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Distributed By: CVS Pharmacy Inc. One CVS Drive, Woonsocket, RI 02895, NDC 59779-303-01", "product_quantity": "N/A", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #:8G50A, Exp. Date 06/2021"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "84196", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors/wholesalers throughout the United States.", "recall_number": "D-0305-2020", "product_description": "Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-723-10", "product_quantity": "30,516 bottles", "reason_for_recall": "Presence of Foreign substance: identified as a dead ant.", "recall_initiation_date": "20191101", "center_classification_date": "20191107", "termination_date": "20210304", "report_date": "20191113", "code_info": "Lot #: F802345, F802346, F802347, Exp 11/20"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80365", "recalling_firm": "World Organix, LLC", "address_1": "6149 S. Rainbow Blvd #5", "address_2": "N/A", "postal_code": "89118", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1124-2018", "product_description": "Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, 12mL bottle. Distributed by World Organix LLC Las Vegas Nevada.  UPC#7 14983 56525 7", "product_quantity": "681  12 mL-bottle", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.", "recall_initiation_date": "20180626", "center_classification_date": "20180823", "termination_date": "20240930", "report_date": "20180815", "code_info": "Lot Code: 2001. Best by date: 03/2019"}, {"status": "Terminated", "city": "Wilsonville", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69519", "recalling_firm": "Oregon Compounding Centers, Inc. dba Creative Compounds", "address_1": "8560 Sw Salish Ln Ste 100", "address_2": "N/A", "postal_code": "97070-9625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Oregon, Washington", "recall_number": "D-0225-2015", "product_description": "TOBRAMYCIN, 480mg/1000 mL, solution for irrigation, 500 mL plastic bottle, RX, Creative Compounds, Wilsonville, OR 97070", "product_quantity": "1000 mL", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection", "recall_initiation_date": "20141006", "center_classification_date": "20141031", "termination_date": "20150630", "report_date": "20141112", "code_info": "Lot #: 20140912@16, discard date: 10/17/2014"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1658-2019", "product_description": "fentaNYL 0.05MG/ML INJ SOL (PF), 55ML per syringe (C-II) RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0118-55", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93453", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0125-2024", "product_description": "Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For Topical Ophthalmic Use Only, Not for IV Use, This is a Compounded Drug, Hospital & Office Use Only, Fagron Sterile Services, 8710 E 34th St N Wichita, KS 67226.  NDC 71266-8240-01", "product_quantity": "756 bottles", "reason_for_recall": "Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper", "recall_initiation_date": "20231110", "center_classification_date": "20231128", "report_date": "20231206", "code_info": "Lot #:  C274-000033372, Exp. Date 01-17-2024; C274-000033764, Exp. Date 02-06-2024", "more_code_info": ""}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64869", "recalling_firm": "Jubilant Cadista Pharmaceuticals Inc.", "address_1": "207 Kiley Dr", "address_2": "", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide", "recall_number": "D-296-2013", "product_description": "Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90", "product_quantity": "12770 bottles", "reason_for_recall": "cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.", "recall_initiation_date": "20130211", "center_classification_date": "20130426", "termination_date": "20131223", "report_date": "20130508", "code_info": "Lot PA22028 Exp 5/2014  Lot PA22029 Exp 5/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["GOOD SENSE CHILDRENS PAIN AND FEVER"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["L. Perrigo Company"], "product_ndc": ["0113-0020"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["6a40ccda-7066-4848-9033-bf2d4f47fcb7"], "spl_set_id": ["61a88a72-cf4f-4ec9-bc24-e110adfb98ba"], "package_ndc": ["0113-0020-26", "0113-0020-28", "0113-0020-34"], "is_original_packager": [true], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0602-2022", "product_description": "Acetaminophen Child Bubble Gum Flavored Oral Suspension (160 mg/5 ml), 4 FL OZ (118 mL) per bottle, Distributed by Perrigo, Allegan, MI 49010.  NDC: 0113-0020-26", "product_quantity": "3,024 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1CK0963, Exp 12/31/2022", "more_code_info": ""}, {"country": "United States", "city": "North Brunswick", "address_1": "1385 Livingston Ave", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "address_2": "", "product_quantity": "2592 Blister Packs", "code_info": "Lot #: 2625094, Exp 06/2016", "center_classification_date": "20150618", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Loratadine Orally Disintegrating Tablets USP, 10 mg, Antihistamine, Allergy Relief, 24 Hour, 30 Orally Disintegrating Tablets per blister pack, a) Distributed by CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, UPC 050428113677 (CVS brand, b) Distributed by: Walgreen Co. 200 Wilmot Rd, Deerfield, IL 60015, UPC 311917155623 (Walgreens brand)", "report_date": "20150624", "classification": "Class III", "openfda": {}, "recalling_firm": "Ohm Laboratories, Inc.", "recall_number": "D-1142-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71334", "termination_date": "20160815", "more_code_info": "", "recall_initiation_date": "20150504", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90676", "recalling_firm": "Akorn, Inc", "address_1": "5605 Centerpoint Ct Ste B", "address_2": "", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1361-2022", "product_description": "PrednisoLONE Oral Solution USP, 15 mg per 5 mL, 240 ml bottle, Rx Only, HI-TECH PHARMACAL CO., INC., Amityville, NY 11701. NDC: 50383-042-24", "product_quantity": "14,712 bottles", "reason_for_recall": "Defective Container: Product has incomplete induction seals.", "recall_initiation_date": "20220801", "center_classification_date": "20220819", "report_date": "20220824", "code_info": "Lot#  379804, Exp. 8/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90091", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA", "recall_number": "D-0854-2022", "product_description": "Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY  10017, NDC 0009-0068-07.", "product_quantity": "110 bottles", "reason_for_recall": "Failed Dissolution Specifications: low out of specification results for dissolution.", "recall_initiation_date": "20220428", "center_classification_date": "20220506", "termination_date": "20230713", "report_date": "20220518", "code_info": "Lot #: DX7983, exp. date 02/28/2023"}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80213", "recalling_firm": "ICU Medical Inc", "address_1": "600 N FIELD DRIVE", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-0885-2018", "product_description": "5% Dextrose Injection, USP, 250 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7922-02", "product_quantity": "267288 bags", "reason_for_recall": "Lack of assurance of sterility: Bags have potential to leak.", "recall_initiation_date": "20180531", "center_classification_date": "20180620", "termination_date": "20200604", "report_date": "20180627", "code_info": "Lot #: 86-033-JT, Exp 08/01/2019"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0827-2019", "product_description": "Dr. King's SafeCare Rx Restless Leg Syndrome, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955044529, NDC 57955-0445-2", "product_quantity": "143 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 051716X Exp. 05/19; 101116A Exp. 10/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1381-2016", "product_description": "10 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride;, 10 mL in 12 mL Monoject Syringe, Service Code 2T6014 (NDC 61553-014-20), 50 mL in 60 mL BD Syringe , Service Code 2T6636 (NDC 61553-636-27), Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141", "product_quantity": "600 Monoject Syringes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2T6014 , Lot Number 160390220M , Exp. Date 5/9/2016 ;  Service Code 2T6014 , Lot Number 160700029M , Exp. Date 6/8/2016 ;  Service Code 2T6636 , Lot Number 160380145M , Exp. Date 5/7/2016 ;  Service Code 2T6636 , Lot Number 160390003M , Exp. Date 5/8/2016 ;  Service Code 2T6636 , Lot Number 160460177M , Exp. Date 5/15/2016 ;  Service Code 2T6636 , Lot Number 160490165M , Exp. Date 5/18/2016 ;  Service Code 2T6636 , Lot Number 160550201M , Exp. Date 5/24/2016 ;  Service Code 2T6636 , Lot Number 160670237M , Exp. Date 6/6/2016 ;  Service Code 2T6636 , Lot Number 160680008M , Exp. Date 6/6/2016 ;  Service Code 2T6636 , Lot Number 160700023M , Exp. Date 6/8/2016 ;  Service Code 2T6636 , Lot Number 160710003M , Exp. Date 6/9/2016 ;  Service Code 2T6636 , Lot Number 160740258M , Exp. Date 6/13/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65125", "recalling_firm": "THE COMPOUNDING SHOP, INC.", "address_1": "4000 Park St N", "address_2": "N/A", "postal_code": "33709-4034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, California, Minnesota, and Maine", "recall_number": "D-559-2013", "product_description": "Lipoic Acid 25 mg/mL Injectable, 100 mL vials, compounded by The Compounding Shop, St. Petersburg, FL", "product_quantity": "55 vials of 100mL", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130502", "center_classification_date": "20130604", "termination_date": "20240930", "report_date": "20130612", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0512-2023", "product_description": "Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703", "product_quantity": "a) 375 Bottles b) 323 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "a) Lot: B1522B, Exp 4/30/2023; lot:C0222H, C0322B, Exp 5/31/2023; lot: E1022H, F13220, H2222P, Exp 6/30/2023; Lot: I1422V, K01220, Exp 12/31/2023; Lot: L2722H, Exp 3/31/2024; b) Lot:C0322B, Exp 5/31/2023; lot:H1122G, 12322Q, Exp 6/30/2023; lot: J1222U, Exp 12/31/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "64680", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-578-2013", "product_description": "Disulfiram Tablets USP 250 mg, 100 tablet bottle, Rx only, Manufactured for TEVA Pharmaceuticals, USA, Sellersville, PA --- NDC 0093-5035-01", "product_quantity": "68,322 bottles", "reason_for_recall": "CGMP Deviation; cotton coil is missing in some packaged bottles", "recall_initiation_date": "20130319", "center_classification_date": "20130606", "termination_date": "20131224", "report_date": "20130612", "code_info": "NDC 0093-5035-01, Lot numbers 14064211A, exp 3/2014; 14064311A, exp 3/2014; 14064411A, exp 3/2014; 14064511A, exp 3/2014; 14090312A, exp 4/2015; 14092512A, exp 4/2015; 14092712A, exp 4/2015; 14094612A, exp 4/2015; 14099412A, exp 4/2015; 14099612B, exp 4/2015; 14099712A, exp 5/2015; 14110111A, exp 5/2014; 14110211A, exp 5/2014; 14110311A, exp 5/2014; 14110411A, exp 5/2014 and 34090212A, exp 4/2015."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0140-2015", "product_description": "Testosterone cypionate 200 mg/mL injection  packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "2,500 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06112014@14, Exp 9/9/2014; 07312014@17, Exp 10/29/2014; 08202014@1, Exp 11/18/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-874-2015", "product_description": "Quinine Sulfate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5800 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0598-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-208-15", "product_quantity": "11,555 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-003", "product_description": "Lamotrigine Tablets, USP, 200 mg, packaged in a) 60-count bottles (NDC 0378-4254-91) and b) 500-count bottles (NDC 0378-4254-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "28,140 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: a) 2003194, 2003195; b) 2003193"}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66188", "recalling_firm": "Wellness Pharmacy, Inc.", "address_1": "3401 Independence Drive Suite 231", "address_2": "N/A", "postal_code": "35209-8326", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1034-2013", "product_description": "RL Glutathione 100 mg/mL, SDV PF,a) 1 mL, b) 2 mL, c) 3 mL, and d) 4 mL, WELLNESS PHARMACY, 1-800-227-2627", "product_quantity": "34 Vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20140603", "report_date": "20130918", "code_info": "Lot# 130710@27, Use By:  1/6/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93354", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distributed to one direct account in Florida with possible further distribution out of state.", "recall_number": "D-0099-2024", "product_description": "V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by:  BioActive Nutritional, Inc., 1803 N. Wickham Rd., Melbourne, FL 32935", "product_quantity": "1,333 30mL bottles", "reason_for_recall": "Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).", "recall_initiation_date": "20231030", "center_classification_date": "20231109", "termination_date": "20240512", "report_date": "20231115", "code_info": "Lot: Z65842 no exp date on product", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209207"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-2130"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["39623a94-8b73-17c6-e063-6294a90a4c31"], "spl_set_id": ["f4dad3d6-1366-4bdf-99eb-370ab74a6b9e"], "package_ndc": ["51672-2130-8", "51672-2130-1"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0301-2020", "product_description": "Children's Ibuprofen Oral Suspension USP, 100 mg per 5 mL, Berry Flavor, Dye-Free, Alcohol Free,  8 fl. oz.(240 mL), Distributed by: Taro Pharmaceuticals, U.S.A., Inc., Hawthorne, NY 10532,  NDC 51672-2130-1", "product_quantity": "5,190 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: J871033187, Exp 9/20", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3", "68968-5554-01"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "62002", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1413-2012", "product_description": "Daytrana (Methylphenidate) Transdermal System Patch, Delivers 20 mg over 9 hours (2. 2 mg/hr), 1 patch per pouch (NDC 68968-5554-01) packaged in 3-count patches per box (NDC 68968-5554-3) , Rx only, Manufactured  for Shire US Inc., Wayne, PA 19087 by Noven Pharmaceuticals, Inc., Miami, FL 33816.08/04/12.", "product_quantity": "185,160 patches", "reason_for_recall": "Miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value", "recall_initiation_date": "20120322", "center_classification_date": "20120712", "termination_date": "20140509", "report_date": "20120718", "code_info": "Lot # 53995", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-522-2015", "product_description": "Anastrozole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "615 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1229-2019", "product_description": "Heparin Pork 30,000 Units in NS 1000 mL bag, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "87 bags", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED091908 Exp. 4/18/2019; ED101908 Exp. 4/19/2019"}, {"status": "Ongoing", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210664"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["3b12eb84-4431-551b-e063-6294a90acd6c"], "spl_set_id": ["3fb9f5ad-90a2-4858-bc34-f800d8b2fa90"], "package_ndc": ["42192-501-50", "42192-501-05"], "is_original_packager": [true], "upc": ["0342192501058"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "97716", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110", "address_2": "", "postal_code": "30005-1795", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0014-2026", "product_description": "Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.", "product_quantity": "4,680 500-count bottles", "reason_for_recall": "Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.", "recall_initiation_date": "20250929", "center_classification_date": "20251009", "report_date": "20251015", "code_info": "Lot #: P24ZLK1, Exp 5/31/2027", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83908", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors throughout the United States who may have further distributed the product.", "recall_number": "D-0178-2020", "product_description": "Ranitidine Tablets, USP 75 mg, NDC 57896-715  (GeriCare) OTC.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191001", "center_classification_date": "20191105", "report_date": "20191113", "code_info": "Batch Numbers:  All lots within expiry."}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0939-2020", "product_description": "AscorbiX (Buffered C) Injection, Ascorbix (30ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07112019+52635, Exp 1/17/2020; 09092019+52890, Exp 3/17/2020"}, {"status": "Terminated", "city": "Xiamen", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91410", "recalling_firm": "GFA Production Xiamen Co. Ltd.", "address_1": "Huli Industrial Park No. 20", "address_2": "Meixi Road; Tong'An", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada.", "recall_number": "D-0248-2023", "product_description": "Easy Care First Aid 25 Person 2009 ANSI, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 9999-2129", "product_quantity": "37464 packets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.", "recall_initiation_date": "20221223", "center_classification_date": "20230127", "termination_date": "20250729", "report_date": "20230208", "code_info": "Lot # W05L28, exp 12/28/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-780-2015", "product_description": "Metaxalone active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Kearney", "state": "NE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67260", "recalling_firm": "Slim Beauty USA", "address_1": "503 E 23rd St", "address_2": "N/A", "postal_code": "68847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1222-2014", "product_description": "Dream Body Slimming Capsule (Chinese bitter orange 24%, Cassia Seed 18%, Aloe 16%, Lotus Leaf Extract 12%, Medical Amylum 30%), 350 mg, 30-count bottles, Made in China (Beijing).", "product_quantity": "3 bottles", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and . Sibutramine is not currently marketed in the United States, making this product an unapproved new drug.", "recall_initiation_date": "20131210", "center_classification_date": "20140407", "termination_date": "20170314", "report_date": "20140416", "code_info": "Lot # 20130328, Exp 3/27/15"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63509", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-016-2013", "product_description": "Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/35 mcg, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA; Distributed by: Watson Pharma, Inc.; NDC 52544-554-28.", "product_quantity": "1,684 cartons", "reason_for_recall": "Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).", "recall_initiation_date": "20121019", "center_classification_date": "20121024", "termination_date": "20131121", "report_date": "20121031", "code_info": "Lot # 512642B, Exp 08/31/13"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "318 vials", "code_info": "Lot #: a) Bacteriostatic Sodium Chloride 0.9% 30 mL, 20121205, Exp 6/11/2013; b) Sodium Chloride 23.4% 30 mL PF: 20130115-G, Exp 4/15/2013; c) Sodium Chloride 23.4% 50 mL: 20130114-E, Exp 4/14/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Sodium Chloride Injection, all strengths and all presentations including a) Bacteriostatic Sodium Chloride 0.9% 30 mL, b) Sodium Chloride 23.4% 30 mL PF, and c) Sodium Chloride 23.4% 50 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-408-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-524-2015", "product_description": "Artemether active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #\"s:  0392538    0391562    0391564", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CISPLATIN 1MG/ML INJECTABLE 1000 ML, 2000 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1485-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Annapolis", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89209", "recalling_firm": "Valgene Incorporated dba Cape Drugs", "address_1": "1384 Cape St Claire Rd", "address_2": "", "postal_code": "21409-5325", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Maryland Only", "recall_number": "D-0284-2022", "product_description": "B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409", "product_quantity": "12 vials", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20211203", "center_classification_date": "20211215", "termination_date": "20220104", "report_date": "20211222", "code_info": "Lot# 190036, BUD 12/27/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0693-2019", "product_description": "Dr. King's Natural Medicine Rosacea Symptom Relief Homeopathic Topical Lotion, 3 oz. (85 g), King Bio, Inc., 3 Westside dr. Asheville, NC 28806 USA, UPC 357955091936, NDC 57955-0919-3", "product_quantity": "3211 tubes", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021117ZZ Exp. 02/19; 031918ZZ Exp. 03/20; 110217ZZ Exp. 09/19"}, {"status": "Terminated", "city": "Davie", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201089"], "brand_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "generic_name": ["DICLOFENAC SODIUM AND MISOPROSTOL"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0397", "0591-0398"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICLOFENAC SODIUM", "MISOPROSTOL"], "rxcui": ["857706", "1359105"], "spl_id": ["03f24a4c-0fe7-446a-b64d-a7c6b12cae0f"], "spl_set_id": ["df8b8660-0c24-4848-8bea-c1b935090c66"], "package_ndc": ["0591-0397-19", "0591-0397-60", "0591-0398-60"], "is_original_packager": [true], "nui": ["N0000175785", "M0017811"], "pharm_class_epc": ["Prostaglandin E1 Analog [EPC]"], "pharm_class_cs": ["Prostaglandins E, Synthetic [CS]"], "unii": ["0E43V0BB57", "QTG126297Q"], "upc": ["305910398606"]}, "product_type": "Drugs", "event_id": "69237", "recalling_firm": "Actavis Laboratories, FL, Inc.", "address_1": "4955 Orange Dr", "address_2": "N/A", "postal_code": "33314-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1616-2014", "product_description": "Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.", "product_quantity": "36,538 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.", "recall_initiation_date": "20140424", "center_classification_date": "20140930", "termination_date": "20161223", "report_date": "20141008", "code_info": "Lot #: 605956A, 605958A, Exp. 9/30/2014; 644678M, Exp. 10/31/2014; 661841A, Exp. 11/30/2014; 717469A, Exp 2/28/2015"}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["LOTRIMIN DAILY PREVENTION DEO"], "generic_name": ["TOLNAFTATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-0010"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["TOLNAFTATE"], "rxcui": ["705934"], "spl_id": ["289dbd00-e2f2-0998-e063-6394a90ae1a4"], "spl_set_id": ["9e8bfb78-ad81-93d0-e053-2995a90aa41d"], "package_ndc": ["11523-0010-1", "11523-0010-2", "0004110059"], "is_original_packager": [true], "unii": ["06KB629TKV"], "upc": ["041100587206", "011017408239"]}, "product_type": "Drugs", "event_id": "88677", "recalling_firm": "Bayer Healthcare Pharmaceuticals Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.", "recall_number": "D-0254-2022", "product_description": "LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, UPC 0 41100 58720 6, NDC 11523-0010-2; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, Packaged with LOTRIMIN ULTRA (butenafine hydrochloride 1%) cream, UPC 0 11017 40823 9, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Japan,  ECOM PK   UPC 00041100590756 NDC 11523-0010-2", "product_quantity": "579,456 units", "reason_for_recall": "cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.", "recall_initiation_date": "20211001", "center_classification_date": "20211118", "termination_date": "20230626", "report_date": "20211124", "code_info": "Lot # NAA8997, EXP 01/31/2022; NAA8EK8, EXP 02/28/2022; NAA9E18, NAA9LFP, NAA9T53, NAA5RW, EXP 08/31/2022;", "more_code_info": ""}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "41 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "methylcobalamine 1 mg/mL, 1 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0686-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["MINIVELLE"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-6610", "68968-6625", "68968-6637", "68968-6650", "68968-6675"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632", "1356979", "1356997", "1357007", "1357009", "1551622"], "spl_id": ["58e55d14-a9df-4814-9b60-b7c9ce37b0b7"], "spl_set_id": ["6c5c47ab-28ee-11e1-bfc2-0800200c9a66"], "package_ndc": ["68968-6625-8", "68968-6637-8", "68968-6650-8", "68968-6675-8", "68968-6610-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "80997", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1210-2018", "product_description": "Minivelle (estradiol transdermal system) Patches, Delivers 0.075 mg/day, 8 count boxes, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. By: Noven Therapeutics, LLC. Miami, Florida 33186 --- NDC 68968-6675-8", "product_quantity": "74908 boxes of 8 patches", "reason_for_recall": "Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.", "recall_initiation_date": "20180907", "center_classification_date": "20180925", "termination_date": "20200909", "report_date": "20181003", "code_info": "Lots: 82599 Exp. 05/2019; 82660 Exp. 03/2019; 83396 Exp. 09/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1168-2020", "product_description": "Vertigo Off, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1022-2015", "product_description": "Keto 10%-Gabap 10%-Ketamine 2% Cream, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 151209-24, BUD: 06/06/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "MOLYBDENUM 250MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1227-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t12-19-2016@69, Exp 5/22/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 10/15/2.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/2.5mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0736-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "40 bags", "code_info": "LOT # 20170509@29, Use By: 08/07/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectable, 4g, Total Approximate Volume 108 mL (does not include mfg. overfill) Single Dose Container bag, Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205,  NDC: 70004-0737-32", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0878-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:NICOTINE POLACRILEX, GUM, 2 mg may have potentially been mislabeled as one of the following drugs:  FOLIC ACID, Tablet, 1 mg, NDC 65162036110, Pedigree: AD33897_22, EXP: 5/9/2014;  QUEtiapine FUMARATE, Tablet, 25 mg, NDC 60505313001, Pedigree: W003099, EXP: 6/13/2014.", "address_2": "", "product_quantity": "1210 Pieces", "code_info": "NICOTINE POLACRILEX, GUM, 2 mg has the following codes:   Pedigree: AD33897_28, EXP: 2/28/2014;  Pedigree: W003100, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NICOTINE POLACRILEX, GUM, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00536302923.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-925-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bangalore, Karnataka", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67580", "recalling_firm": "Agila Specialties Private Ltd.", "address_1": "Sterile Product Division, Opp IIM,", "address_2": "Bilekahalli, Bannerghatta Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1225-2014", "product_description": "etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDC 0069-0006-02), 10 x 10 mL vials per carton (NDC 0069-0006-01) and b) 40 mg/20 mL (2 mg/mL) 20 mL Single Dose Vials (NDC 0069-0006-04), 10 x 20 mL vials per carton (NDC 0069-0006-03), Rx only, Distributed by Pfizer Labs; Division of Pfizer Inc., New York, NY  10017.", "product_quantity": "7919 cartons", "reason_for_recall": "Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.", "recall_initiation_date": "20140214", "center_classification_date": "20140408", "termination_date": "20151203", "report_date": "20140416", "code_info": "Lot #: a) 5000983, 5000986, Exp 08/14; 5001023, Exp 09/14; b) 5000927, 5000931, 5000936, 5000942, 06/14; 5001012, 5001040, Exp 09/14; 5001071, Exp 10/14"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-642-2013", "product_description": "Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "35ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCAFBB:81, Exp date: 5/4/2013; Lot number CABCCEAJ:85 Exp date: 3/23/2013 and Lot number CABDCFAC:25 Exp date: 8/24/2013."}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64716", "recalling_firm": "Pallimed Solutions", "address_1": "400 W Cummings Park", "address_2": "", "postal_code": "01801-6519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-864-2013", "product_description": "Cyclosporine Ophthalmic, compounded by Pallimed Solutions Pharmacy, Woburn, MA", "product_quantity": "", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130325", "center_classification_date": "20130809", "termination_date": "20130821", "report_date": "20130821", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Pine Level", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62775", "recalling_firm": "Custom Medical Specialties, Inc.", "address_1": "330 East Main Street", "address_2": "N/A", "postal_code": "27568", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "GA, MD, MA", "recall_number": "D-1649-2012", "product_description": "Custom Access Tray, Sterile, contains Sodium Chloride 0.9% 50 mL, Re-order #: CMS-1667-R2(94-2478), Manufactured for KM Medical, Inc., 124 Jewett Street, Georgetown, MA 01833, the tray also contains other components not listed in this product description.", "product_quantity": "35 Trays", "reason_for_recall": "Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags", "recall_initiation_date": "20120723", "center_classification_date": "20120817", "termination_date": "20121011", "report_date": "20120829", "code_info": "Lot #: 25744-1111, Exp 09/2012"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0126-2016", "product_description": "TESTOSTERONE, Pellet, 106 mg,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "4 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12082014@45, t05122015@7, t04012015@13, t03062015@7."}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82310", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "N/A", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0991-2019", "product_description": "Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT  06877 USA, Made in Germany, NDC 0597-0190-61.", "product_quantity": "112 folding cartons", "reason_for_recall": "Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.", "recall_initiation_date": "20190307", "center_classification_date": "20190311", "termination_date": "20190911", "report_date": "20190320", "code_info": "Lot # AA3280A, Exp SEP 2019"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ITRACONAZOLE, Capsule, 100 mg may be potentially mislabeled as     FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD54549_4, EXP: 5/20/2014.", "address_2": "", "product_quantity": "30 Capsules", "code_info": "ITRACONAZOLE, Capsule, 100 mg has the following code    Pedigree: AD54549_10, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ITRACONAZOLE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10147170003", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-499-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0171-2018", "product_description": "Chloramphenicol 500 mg Sulfamethoxazole 500 mg Amphotericin 50 mg Otic Powder packaged in jars, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "100 jars", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lots: 07282017@24 BUD: 1/24/2018; 08162017@33 BUD: 2/12/2018", "more_code_info": ""}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "3928 Cases", "code_info": "Product Code: 6964; Lots: 56718, EXP 09/26/2017; 57387, 57414, 57423, EXP 11/13/2017; 58272, EXP 04/03/2018; 59592, EXP 07/16/2018; 60142, EXP 08/02/2018; 60541, EXP 09/04/2018; 60767, EXP 09/06/2018; 61159, EXP 09/11/2018; 61467, EXP 10/16/2018; 62075, EXP 11/12/2018.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Q.Care Oral Cleansing & Suctioning System Suction Toothbrush Compatible with Chlorhexidine Gluconate (CHG) Oral Rinse q4. Contains 1 Covered Yankauer and Y-Connector, 1 Untreated Suction Toothbrush packages,  2 Single dose bottles of 0.12% CHG Oral Rinse, 4 Suction Oral Swab packages with Corinz Antiseptic Cleansing and Moisturizing Oral Rinse, 2 Oropharyngeal Suction Catheter packages. Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. Product Code 6964 UPC 6 18029 83075 3", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0405-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0350-2021", "product_description": "ChloraPrep With Tint 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution - Hi-Lite Orange, 0.10 fl. oz. (3 ml) each, 25 applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-11 Cat. No. 260415", "product_quantity": "7,990,100 cartons", "reason_for_recall": "CGMP Deviations:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lots and Exp dates:  0009104, 12/31/2022;  0013602, 12/31/2022;  0016431, 1/31/2023;  0022273, 1/31/2023;  0023788, 1/31/2023;  0029135, 1/31/2023;  0032694, 1/31/2023;  0038211, 1/31/2023;  0044741, 1/31/2023;  0064598, 2/28/2023;  0104862, 3/31/2023;  0127010, 4/30/2023;  0196060, 6/30/2023;  0224915, 7/31/2023;  8024958, 1/9/2021;  8025595, 1/31/2021;  8025597, 1/31/2021;  8031857, 1/31/2021;  8033645, 1/31/2021;  8038971, 1/28/2021;  8043969, 1/22/2021;  8043978, 1/31/2021;  8046513, 2/1/2021;  8046721, 1/29/2021;  8053669, 2/28/2021;  8053699, 2/28/2021;  8053947, 2/28/2021;  8055949, 2/28/2021;  8059513, 2/28/2021;  8059562, 2/28/2021;  8061970, 2/19/2021;  8064854, 2/28/2021;  8066666, 2/28/2021;  8068686, 2/28/2021;  8069986, 2/28/2021;  8073868, 2/28/2021;  8087798, 3/31/2021;  8099735, 3/31/2021;  8101641, 3/31/2021;  8106743, 4/30/2021;  8107945, 4/30/2021;  8120678, 4/30/2021;  8122947, 4/30/2021;  8131539, 4/30/2021;  8145833, 5/31/2021;  8155989, 5/31/2021;  8172690, 6/30/2021;  8173860, 6/30/2021;  8191600, 6/30/2021;  8221942, 7/31/2021;  8234936, 8/31/2021;  8243851, 8/31/2021;  8247688, 8/31/2021;  8250928, 8/31/2021;  8253987, 8/31/2021;  8256638, 8/31/2021;  8260782, 8/31/2021;  8265685, 9/30/2021;  8274504, 9/30/2021;  8276704, 9/30/2021;  8282698, 9/30/2021;  8284625, 9/30/2021;  8288853, 9/30/2021;  8338776, 11/30/2021;  8339985, 11/30/2021;  8351538, 12/31/2021;  8355672, 12/31/2021;  9007942, 12/31/2021;  9014571, 12/31/2021;  9017726, 1/31/2022;  9021969, 12/31/2021;  9024576, 1/31/2022;  9030949, 1/31/2022;  9078586, 3/31/2022;  9087987, 3/31/2022;  9092771, 3/31/2022;  9128867, 4/30/2022;  9129671, 4/30/2022;  9135822, 5/31/2022;  9143840, 5/31/2022;  9154907, 5/31/2022;  9154939, 5/31/2022;  9158658, 5/31/2022;  9164579, 5/31/2022;  9175663, 6/30/2022;  9176284, 6/30/2022;  9197931, 6/30/2022;  9199822, 6/30/2022;  9200426, 7/31/2022;  9205380, 7/31/2022;  9207927, 7/31/2022;  9213913, 7/31/2022;  9221459, 7/31/2022;  9224855, 7/31/2022;  9231815, 8/31/2022;  9232764, 8/31/2022;  9233646, 8/31/2022;  9235839, 8/31/2022;  9248040, 8/31/2022;  9261980, 9/30/2022;  9270896, 9/30/2022;  9301763, 10/31/2022;  9310176, 10/31/2022;  9317270, 11/30/2022;  9327966, 11/30/2022;  9327969, 11/30/2022;  9339209, 11/30/2022;  9344806, 11/30/2022;  9345964, 10/31/2022;  9351402, 12/31/2022;", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "79 units", "code_info": "Rx #'s:   0402964    0402963    0398083        0398557    0398524      0406883    0396497    0401829    0407441    0408458    0408393    0398196    0398084        0405518    0397074      0401694    0401412    0398196    0404325      0397888    0407444    0408529    0408099    0401897            0402614    0405996    0402614    0405382      0398014    0398022    0400197      0400116    0400197      0401897    0405996    0398014      0402614    0398014    0401755    0401755      0404391      0402616      0401688    0398026    0399744      0402617      0398026    0401755    0398026    0402616    0400850    0404643    0408996    0403960    0400509    0400960    0403759    0404643    0405771", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.25% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL & EPINEPHRINE, P.F. 0.5% / 1:200,000 INJECTABLE 900 ML; BUPIVACAINE HCL 0.25% INJECTABLE 120 ML,180 ML, 240 ML, 250 ML, 300 ML, 500 ML, 60 ML; BUPIVACAINE HCL 0.5% INJECTABLE1000 ML, 120 ML, 200 ML, 250 ML, 400 ML, 50 ML, 500 ML, 600 ML, 750 ML; BUPIVACAINE HCL, P.F. 0.25% INJECTABLE\t1000 ML, 120 ML, 1200 ML, 150 ML, 1500 ML, 180 ML, 240 ML, 300 ML, 60 ML, 600 ML, 900 ML; BUPIVACAINE HCL, P.F. 0.5% INJECTABLE 10 ML, 120 ML, 1500 ML, 20 ML, 200 ML, 240 ML, 2500 ML, 300 ML, 360 ML, 600 ML, 960 ML; BUPIVACAINE HCL, P.F. 0.75% INJECTABLE 1200 ML, 150 ML, 240 ML, 30 ML, 600 ML, 7 ML (47 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1470-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "6 ml", "code_info": "All lots distributed between November 2014 and May 2015; 04292015@78, 10/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (20/1/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1769-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "296 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  04142015@64, 7/13/2015; 02252015@4, 5/26/2015; 03162015@59, 6/14/2015;  03242015@71, 6/22/2015; 04222015@17, 6/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 35 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1597-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077559"], "brand_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "generic_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-173"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE", "IPRATROPIUM BROMIDE"], "rxcui": ["1437702"], "spl_id": ["914605d4-7326-445d-b20e-6771eb67f7c4"], "spl_set_id": ["3c64255e-074c-41f8-a344-3686a0685020"], "package_ndc": ["69097-173-64", "69097-173-53"], "is_original_packager": [true], "unii": ["021SEF3731", "J697UZ2A9J"]}, "product_type": "Drugs", "event_id": "94289", "recalling_firm": "Cipla USA, Inc.", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0471-2024", "product_description": "Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53", "product_quantity": "59244/3ml FFS packs", "reason_for_recall": "Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.", "recall_initiation_date": "20240326", "center_classification_date": "20240424", "termination_date": "20250709", "report_date": "20240501", "code_info": "Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0188-2023", "product_description": "Methylcobalamin 1MG/ML (1ML vial); Methylcobalamin 3MG/ML (1ML vial); Methylcobalamin 5MG/ML (1ML vial) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221021@36 t20221025@32 t20221025@33", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-971-2013", "product_description": "KETOROLAC TROMETHAMINE  60 MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "03202013@25", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-723-2015", "product_description": "Hydroxyurea active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4250 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.", "address_2": "", "product_quantity": "1200 capsules", "code_info": "69MO EXP 05/13, 69SH EXP 05/13, 5KXZ EXP 05/12, 5RE1 EXP 05/12", "center_classification_date": "20130327", "distribution_pattern": "FL, NC, TX, CO, VA, SC, GA, KS, LA, MO", "state": "OK", "product_description": "PHYSICIANS TOTAL CARE, TETRACYCLINE, 250 mg, 30 CAPSULES, bottle MFG. BY: TEVA PHARMACEUTICALS USA, SELLERSVILLE PA 18960 NDC 54868-0024-08", "report_date": "20130403", "classification": "Class II", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-221-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63891", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20120220", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]